Indefinite Delivery Contract 36E79725D0006

Award Date 3/15/25
Last Date to Order 3/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and...
The Indefinite Delivery Contract (IDC) awarded to Sanofi Pasteur Inc. by the National Acquisition Center, a component of the Department of Veterans Affairs (VA), is for the procurement of Influenza Virus Vaccine for the 2025-2026 influenza season. The contract has a Period of Performance from March 15, 2025 to March 14, 2026, and a ceiling value of $113,670.50. As the prime contractor, Sanofi Pasteur Inc. will provide seasonal influenza vaccines to support requirements for the VA, State...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Seqirus USA Inc., a global biotechnology company specializing in the development, manufacturing, and delivery of influenza vaccines. The contract, valued at $2,555,130.00, is for the procurement of a wide range of influenza vaccine products, including multi-dose vials, pre-filled syringes, and specialized vaccines for different age groups. The contract is intended...
The federal contract IDV award is for the procurement of influenza virus vaccines for the 2024-2025 flu season. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. This award is being made by the U.S. Department of Veterans Affairs (VA) National Acquisition Center and will be used to supply vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The...
The Department of Veterans Affairs National Acquisition Center awarded a single award IDV to Seqirus USA Inc. on March 15, 2021 with a potential value of $67,604,685.53. Task orders issued against the IDV by the VA, Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Healthcare Center procure influenza virus vaccines for the 2021-2022 season. Vaccines provided under the IDV and related task orders include those in multi-dose vials and single dose syringes for adults and...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sanofi Pasteur Inc. for the supply of influenza vaccines. Task orders issued by VA, Federal Bureau of Prisons, Indian Health Service, and Department of Health and Human Services procure influenza virus vaccines in pre-filled syringes and multi-dose vials for individuals over 18 years old. Additional line items provide syringes tailored for those 65 and older as well as children ages 36...
The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...
This indefinite delivery contract issued by the Department of Veterans Affairs National Acquisition Center aims to procure influenza virus vaccines for the 2020-2021 season to support the Department of Veterans Affairs, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. The original pre-solicitation notice sought quadrivalent influenza virus vaccines in multiple dose vials and pre-filled single dose syringes for individuals over 18 years of age,...
The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season. The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
  • 36E79725D0006
    Indefinite Delivery Contract
  • 73
    Federal Contract Awards

The National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Seqirus USA Inc. for the procurement of Influenza Virus Vaccines for the 2025-2026 flu season. The $51.6 million contract has a period of performance from March 15, 2025, to March 14, 2026, and will provide vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center.

The contract requires the delivery of various influenza vaccine presentations, including multi-dose vials, pre-filled syringes for adults and pediatrics, and specialized vaccines for the elderly. The agencies have estimated annual requirements ranging from 1,462 to 153,504 units across the different vaccine types. Orders will be placed by the respective agencies and delivered to their facilities throughout the United States, Philippines, and Puerto Rico. This procurement is unrestricted, with no set-aside requirements. The original solicitation, expected to be issued on September 18, 2024, will require at least 50% of each facility's ordered quantity to be delivered between August 15 and September 15, 2025, with the remaining quantity delivered by October 15, 2025.

Generated 11/21/24, 9:08 AM